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Purpose: To determine the spectrum of mutations and phenotypic variability within patients with mutations in membrane-
type frizzled related protein gene (MFRP).
Methods: Individuals were initially ascertained based on a phenotype similar to that previously published in association
with MFRP mutations. Affected patients underwent a full ophthalmic examination (best-corrected visual acuity, slit-lamp
examination,  applanation  tonometry,  and  fundoscopy),  color  fundus  photography,  optical  coherence  tomography,
autofluorescence imaging, and electrophysiology. MFRP was identified by a genome-wide scan in the fourth-largest
autozygous region in one consanguineous family. Sanger sequencing of all the exons and intron-exon boundaries of MFRP
was undertaken in the affected individuals.
Results: Seven affected individuals from four families were identified as having mutations in MFRP. Patients from two
families were homozygous for mutations already previously described (c.1143_1144 insC and c.492 delC), while those
from the other two were compound heterozygous for mutations (c.201G>A and c.491_492 insT, and c.492 delC, and c.
1622_1625 delTCTG), three of which were novel. There was considerable phenotypic variability within and among
families. Autofluorescence imaging revealed the central macula to be relatively well preserved. Foveal cysts and optic
nerve head drusen were present in two of the four families. Electrophysiology results showed rod-cone dystrophy with
mild to moderate reduction in macular function in all affected members.
Conclusions: We report three novel MFRP mutations and expand the phenotypic data available on patients with MFRP
mutations.
Recessive  mutations  in  the  membrane-type  frizzled-
related protein (MFRP, OMIM *606227) gene have recently
been reported to cause human ocular disease. However, two
different phenotypes have been described. Several research
groups have described families with affected members having
high hyperopia, shallow anterior chambers, optic nerve head
drusen, optic nerve head pallor, pigment clumping, and bone-
spicule pigmentation, in both the midperiphery and periphery,
and minimal vascular attenuation [1-3]. A further publication
reported  three  families  with  recessively  inherited
nanophthalmos  recessively  inherited  nanophthalmos  as  a
consequence of upon mutation in MFRP [4]. Interestingly, the
retinas  of  the  affected  patients  showed  patchy
hypopigmentation without any evidence of retinal dystrophy.
The 13-exon MFRP gene was cloned and described in
2001 [5], and is located on chromosome 11q23. It encodes a
transmembrane protein with 579 amino acid residues that is
expressed predominantly in the retinal pigment epithelium
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and ciliary epithelium of the eye, with a weak expression in
the brain [5]. The exact role of MFRP has yet to be established.
It  has  a  frizzled-type  cysteine-rich  domain,  which  is  the
binding motif for Wingless (Wg), a member of the Wnt family
of  proteins.  Several  processes,  such  as  control  of  gene
expression, cell adhesion, planar polarity, proliferation, and
apoptosis involve Wnt signaling. It is suggested that MFRP is
involved  in  the  Frizzled/Wnt  signaling  pathway.  Besides
having a cysteine-rich domain at the C-terminus, the MFRP
protein  contains  an  N-terminal  cytoplasmic  region,  a
transmembrane  domain,  and  an  extracellular  region  with
tandem repeats of two cubilin domains and a low-density
lipoprotein receptor-related sequence [5].
There is a murine model for the Mfrp mutation: the retinal
degeneration  6  (rd6)  mouse.  The  retinal  phenotype  is
characterized by small, evenly spaced white dots throughout
the  retina,  together  with  a  slowly  progressive  retinal
degeneration  of  both  rods  and  cones,  evidenced  by
electroretinography [6]. Later, using the same mouse model,
it  was  reported  that  Mfrp  is  expressed  as  a  dicistronic
transcript  with  another  retinal  dystrophy  causing  gene
C1qtnf5 [7]. C1qtnf5 and Mfrp have been shown to co-localize
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540to the same tissues, and consequently a functional relationship
between the two proteins was inferred [8].
The present report extends our knowledge of the ocular
phenotype. It describes a series of four families with mutations
in MFRP, the largest series reported to date. Three novel
mutations are reported.
METHODS
Seven patients from four families were identified, based on a
phenotype  similar  one  described  in  previous  reports  of
MFRP-related disease [1-3]. This study adhered to the tenets
of the Declaration of Helsinki and was approved by the local
ethics committee.
Clinical  investigations:  Patients  underwent  full
ophthalmic examination (best-corrected visual acuity, slit-
lamp examination, applanation tonometry, and fundoscopy)
at  Moorfields  Eye  Hospital  (London,  UK).  Color  fundus
photography was performed using a Topcon TRC 50IA retinal
camera  (Topcon  Corporation,  Tokyo,  Japan),  fundus
autofluorescence  imaging  using  a  confocal  scanning  laser
ophthalmoscope  (Zeiss  Prototype;  Carl  Zeiss  Inc.,
Oberkochen, Germany) and optical coherence tomography
(OCT)  using  a  SPECTRALIS®  Spectral-domain  OCT
(Heidelberg  Engineering,  Heidelberg,  Germany)  and  a
STRATUSOCT  Model  3000  scanner  (Zeiss  Humphrey
Instruments,  Dublin,  CA).  Color  vision  was  tested  using
Hardy-Rand-Rittler plates (American Optical Co., New York,
NY) and/or the Ishihara pseudoisochromatic plates (Kanehara
Trading Inc., Tokyo, Japan). To seek the role of MFRP in
determining the axial length of the eye, the refractive status
of the obligate carriers was evaluated.
Electrophysiological assessment was performed in four
affected patients. Full-field electroretinograms (ERGs) and
pattern  ERGs  incorporated  the  methods  recommended  by
ISCEV [9,10]. Dark adapted ERGs were recorded following
stimulation with white flashes of intensity between 0.01 and
11.5  cd.s.m−2.  An  additional  red-flash  ERG  from  healthy
individuals who had both a cone and a later rod component,
were  recorded,  to  compare  the  normal  function  of  dark-
adapted cone and rod systems to that of affected individuals.
Generalized photopic cone system function was assessed after
10 min of light adaptation by recording 30 Hz flicker and
single flash ERGs (3.0 cd.s.m−2 flash, 30 cd.m−2 background
illumination). ON-OFF ERGs used an orange stimulus (560
cd.m−2,  duration  200  ms)  superimposed  on  a  green
background (150 cd.m−2). Short wavelength flash ERGs used
a blue stimulus (445 nm, 80 cd/m2) on an orange background
(620 nm, 560 cd/m2).
Molecular genetics: Genomic DNA was extracted from
peripheral blood leukocytes of the donated blood samples
(Nucleon BACC2 kit; GE Healthcare, Buckinghamshire, UK)
after obtaining informed consent. DNA samples from family
1 (consanguineous) were genotyped for 58,614 SNPs using a
Genechip Human Mapping 50K Xba array (Affymetrix, Santa
Clara,  CA).  Samples  were  prepared  by  using  Affymetrix
GeneChip®  Mapping  50K  Xba  Assay  Kit  as  per  the
manufacturer’s instructions (Affymetrix). Briefly, 250 ng of
genomic  DNA  was  digested  with  XbaI  (New  England
Biolabs, Ipswich, MA) for 2 h at 37 °C. It was ligated with an
XbaI adaptor by using T4 DNA ligase. The ligation reaction
was diluted to 1:4 (v/v) with molecular-grade water (Sigma-
Aldrich Corporation, St. Louis, MO) to 100 μl. Ten μl of the
diluted  ligation  mix  was  used  to  set  up  the  following.
Fragment  selection  was  done  by  PCR  in  triplicates.  The
consolidated PCR products were purified using 96-well plates
(Qiagen Gmbh, Hilden, Germany). The concentration of PCR
product  was  quantified  by  using  ND-1000  Nanodrop
spectrometry  (Thermo  Fisher  Scientific,  Waltham,  MA).
Purified PCR product (90 μg) was fragmented with 0.25 units
of fragmentation reagent and labeled with labeling reagent.
Of  the  labeled  product,  70  μl  was  mixed  with  190  μl  of
hybridization reagent, and denatured at 99 °C for 10 min.
Finally, this denatured hybridization cocktail was injected into
Affymetrix  Human  Mapping  StyI  chips  (Affymetrix)  and
incubated at 49 °C for 16 h, followed by automated washing
and staining in a Fluidics Station 450 (Affymetrix). Scanning
was done with a GeneChip® Scanner 3000 7G (Affymetrix).
All  chip  data  were  imported  into  the  GeneChip®
Operating  Software  (Affymetrix)  software  platform  and
genotype data were extracted. The pedigree was consistent
with the propagation of a single mutant allele from a recent
ancestor, such that both affected probands were homozygous
for this allele. A macro was written using the Visual Basic
program in Microsoft Excel (Microsoft, Redmond, WA) to
detect genomic regions obeying this rule.
The MFRP gene was screened for presumed disease-
causing  mutations.  Primers  were  designed  to  amplify  the
coding region and intron-exon boundaries of the 13 published
exons (NM_031433.2; Table 1). All PCRs were performed in
a 25 μl volume containing 1X reaction buffer and 0.1X of
Enhancer (Molzym, Bremen, DE), 200 μm each of dNTP, 10
pMol each forward and reverse primer, 200 ng to 1 μg DNA,
and  1U  Taq  polymerase  (MolTaq,  Molzym).  After  the
denaturation step at 94 °C for 5 min, the amplification was for
34 cycles at 94 °C for 30 s. Annealing was performed at 60 °C
for 30 s, and then at 72 °C for 45 s. The final extension was
at 72 °C for 5 min.
Amplicons  were  run  on  a  2%  (w/v)  low-melting-
temperature agarose gel in 1X Tris-acetate- EDTA (TAE)
buffer to check for the quality and specificity of the PCR
reaction. The products were cleaned, using multiscreen PCR
filter plates (Catalogue no LSKMPCR10, Millipore, Billerica,
MA) before sequencing. Bi-directional Sanger sequencing of
purified  PCR  products  was  performed  using  BigDye
Terminator sequencing Cycle Sequencing Ready Reaction kit
version 1.1 (Applied Biosystems Inc., Foster City, CA) and
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(Applied Biosystems, Warrington, UK). Lasergene version
8.02  sequencing  analysis  software  (DNASTAR  Inc.,
Madison, WI) was used to compare electropherograms with
those from control samples.
RESULTS
Clinical phenotype: The clinical data of the seven patients are
detailed  in  Table  2,  Figure  1,  and  Figure  2.  The  age  of
presentation ranged between 34 and 58 years, although all
patients noticed visual acuity problems from early childhood,
due to hypermetropia. Four of seven patients complained of
night blindness at birth or early childhood, while two did not
report  night  blindness.  Only  one  of  seven  patients  was
photophobic.
Best-corrected visual acuity of the better eye was less
than or equal to 6/60 in five patients; only one patient had
visual acuity better than 6/12. One patient (III-3 of family 2)
lost her central vision at 42 years of age, due to bilateral
progressive serous retinal detachments.
All  seven  patients  were  highly  hypermetropic,  with
spherical equivalents ranging between +13.00 diopters (D)
and +30.00 D. The refractive status of most of the obligate
carriers  in  all  four  families  was  also  examined.  The  two
children of individuals III-2 and III-3 of family 2, the three
children of II-1, and the only child of II-5 of family 1 were
emmetropic.  The  children  of  II-1  of  family  3  were  not
examined. None of the parents of the affected subjects in
families 1, 2, or 3 needed refractive correction, except for
presbyopia.  However,  one  parent  (II-14)  of  the  affected
siblings in family 2 was hypermetropic (spherical equivalent
+3.00  D  for  both  eyes).  Longitudinal  estimation  of  the
refractive status of subject II-5 of family 1 for nearly three
decades  showed  that  the  visual  acuity  and  hypermetropia
remained stable (data not shown). None of the patients had
nystagmus. All three patients tested for color vision failed to
read the test plate.
Retinal examination revealed extensive mid-peripheral
retinal pigment epithelial changes, with relative preservation
of central macular reflex in all patients. There was arteriolar
attenuation  and  intraretinal  pigmentation  (Figure  1).  One
TABLE 1. PRIMERS USED FOR POLYMERASE CHAIN REACTION OF MFRP.
Amplimer Forward primer (5′–3′) Reverse Primer (5′–3′)
1 (Exon 1–Exon 3) CCACTCTACCAAGGACAGCCCAAGAA CATTCCAAAGCCCTCGTTTCAA
2 (Exon 4–Exon 5) CTCTGAACGCCACCCTCCATCTT GCCACTCCCTGATTCTGCTCTTTAGATA
3 (Exon 6–Exon 8) CTCACCCCCAACCTGGCTTCTT GTGTCTACCATGCCATTCCCATTA
4 (Exon 9) GAGACAGGAGAAGGGGCCATGAATT CCGGCCTGGAGTAGCAGAAGAAAA
5 (Exon 10–Exon 11) CCCTAACCCTGTGTCTTCCATCACCTTT CCGACTGTCTTCCAGGACTCTGTGAA
6 (Exon 12–Exon 13) CCACCCCCATTGGACCCATGTA CCTGCTGATGCTCCTTCCTTTGTT
TABLE 2. CLINICAL FEATURES OF THE AFFECTED PATIENTS IN FAMILIES 1–4.
Individual Age in
years
Gender Age on onset of night
blindness
Refractive error
(spherical
equivalent)
Best
corrected
visual acuity
Foveal
cystic
spaces
Optic nerve
head drusen Cataract
Family 1
II–1 58 Female Early childhood – first
decade
+15.00 D right
+16.00 D left
3/60 both eyes Absent Absent Bilateral
cataract
surgery
II–2 53 Female Since birth +19.00 D right
+20.00 left
6/60 both eyes Absent Absent Absent
II–5 46 Female Since birth +13.00 D right
+14.00 D left
6/18 both eyes Absent Absent Absent
Family 2
III–2 50 Female Never +19.00 D right
+20.00 D left
6/9 right
6/12 left
Absent
III–3 47 Female 18 years +18.00 D right
+18.50 D left
NPL right HM
left
Present Absent Bilateral
cataract
surgery
Family 3
II–1 42 Male Early childhood
(before 5 years of age)
+30.00 D right
+27.75 D left
6/60 both eyes Present Present Absent
Family 4
III–1 34 Female Never +17.75 D right
+18.00 D left
6/60 both eyes Present Absent Absent
Abbreviations: D represents Diopters; NPL represents No perception of light; HM represents Hand movements.
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542patient (III-3 of family 2) developed extensive multiple serous
detachments. Optic nerve head drusen were present in only
one (II-1 of family 3) of the seven patients. Autofluorescence
imaging of one affected subject (III-1 of family 4) showed
preservation  of  a  normal  autofluorescence  in  an  elliptical
region  at  the  central  macula,  with  hypo-autofluorescence
observed  in  the  peripheral  macula  (Figure  2).  OCT
examination of three patients (III-3 of family 2, II-1 of family
3, and III-1 of family 4) revealed thickening of the inner layers
and cystic spaces at the fovea, with relative preservation of
the photoreceptor-retinal pigment epithelium complex. There
was thickening of the outer retinal tissue, over and above the
cysts, in at least one patient (II-1 of family 3). The foveal
thickness varied from 502 μm to 673 μm.
Electrophysiology:  Bright  flash  (Figure  3)  dark-adapted
ERGs showed marked a-wave reduction, in keeping with loss
of rod photoreceptor function. Scotopic red flash ERGs had
an undetectable rod component and a severely delayed cone
component. Photopic flicker ERGs were severely delayed and
showed mild to moderate reduction in all cases, in keeping
with generalized retinal cone system dysfunction. There was
an abnormal flicker ERG waveform in patient III-3 of family
2. Single flash cone ERGs were delayed in all four cases, in
addition to mildly subnormal amplitudes in patient II-1 of
family 1 and patient III-2 of family 2. Both the On b-waves
and Off d-waves were delayed in three out three subjects.
Short  wavelength  flash  ERGs  had  a  subnormal  S-cone
component in three out three subjects (II-1 of family 1, III-3
of family 2, and III-1 of family 4). Pattern ERG P50 was
mildly subnormal in three out four subjects, and was within
normal limits in the fourth patient. The phenotype is thus of a
rod-cone  dystrophy,  with  macular  involvement  in  three
patients (III-1 of family 4, II-1 of family 1, and III-3 of family
2), but lacking macular involvement in the fourth (III-2 of
Figure 1. Color fundus photographs of
affected  patients  with  membrane-type
frizzled-related  protein  gene  related
oculopathy. These show the right (A)
and  left  (B)  fundus  photographs  of
subject III-1 of family 4, the right fundus
photograph of individual II-1 of family
1 (C), and the left fundus photograph of
patient III-3 of family 2 (D); all show an
ellipsoid  area  of  macula  with  normal
reflex.  Fundus  photographs  show  the
right (E) and left (F) eye of individual
III-3 of family 2 after developing serous
retinal detachments.
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543family 2).Though there are limited follow-up data available,
ERGs recorded in subject III-3 of family 2, aged 41 years, did
not significantly differ from those recorded 3 years earlier
(data not shown).
Molecular genetics: The pedigrees of each of the families are
illustrated in Figure 4. Family 1 had three affected individuals
born out of a first-cousin marriage. The genome-wide scan
revealed five large regions of autozygosity. The two largest
regions  were  on  chromosome  2,  the  third-largest  on
chromosome 17, the fourth-largest on chromosome 11, and
the smallest on chromosome 4. The fourth region consisted of
12.8  Mb,  which  included  187  contiguous  SNPs.  Upon
interrogating the Ensembl database, one obvious candidate
found  was  the  MFRP  gene.  Sanger  sequencing  of  MFRP
revealed homozygous mutation p.His384Pro fs8X (Table 3),
which  was  segregated  with  disease  among  the  affected
members of the family.
Sequencing of MFRP in affected members of three other
families with similar phenotype, families 2, 3, and 4, revealed
more mutations (Table 3 and Figure 5). Affected individuals
in  family  2  showed  two  novel  compound  heterozygous
mutations  (p.Trp67X  and  p.Asn167Gln  fs34X),  while  the
proband in family 3 was homozygous for a known mutation
(p.Asn167Thr  fs25X)  [4].  The  patient  in  family  4  was
compound heterozygous for one known (p.Asn167Thr fs25X)
[4]  and  one  novel  mutation  (p.Val541Ala  fs188X).  All
mutations led to a premature stop codon.
Figure 2. Autofluorescence images and
high-resolution spectral domain optical
coherence  tomograms  of  affected
patients with membrane-type frizzled-
related protein, and related oculopathy.
Autofluorescence  images  of  the  right
(A) and left (B) eyes of posterior pole of
individual  III-1  of  family  4  show
relative  preservation  of  the  central
macula. Optical coherence tomograms
of the right (C) and left (D) fovea of
individual II-1 of family 3 show areas of
low reflectivity, which are due to cysts
and relative thickening of the retina in
the foveal region.
Molecular Vision 2010; 16:540-548 <http://www.molvis.org/molvis/v16/a61> © 2010 Molecular Vision
544DISCUSSION
This study describes the detailed phenotype of patients having
a  retinal  dystrophy  as  a  consequence  of  homozygous  or
compound  heterozygous  mutations  in  MFRP.  This  report
represents the largest series described to date, and greatly
expands  our  knowledge  of  both  clinical  and
electrophysiological phenotypes and genotypes by reporting
three novel mutations.
All the affected subjects noticed visual difficulties in
childhood,  but  the  onset  of  night  blindness  was  variable.
Patients  from  family  1  and  3  reported  early-onset  night
blindness, while two subjects (III-2 of family 2 and III-1 of
family 4) did not have problems in dim light. Only one patient,
III-3 of family 2, manifested night blindness at 18 years of
age, which was similar to the family described by Ayala-
Ramirez et al., [1] where the proband complained of night
blindness at 24 years of age. The poor visual acuity can be
explained by fovea being affected by the disorder early in the
disease, or by foveal cysts. Because the patients were high
hypermetropes,  amblyopia  could  also  have  contributed  to
reduction in visual acuity.
The refractive analysis of obligate carriers revealed that
only one out of 15 obligate carriers was hypermetropic. Thus,
haploinsufficiency for this gene does not cause a significant
departure  from  optimal  emmetropization,  at  least  in  this
modest  sample.  It  is  therefore  unlikely  that  more  subtle
differences  in  expression  or  function  of  the  MFRP  gene
contribute  to  refractive  error  variability  in  the  normal
population.  This  adds  further  evidence  to  the  previously
published observation that MFRP does not play a significant
role  in  physiologic  hypermetropia  [11].  The  longitudinal
refractive  data  was  stable,  which  suggests  that  the
nanophthalmic component of this disorder progresses slowly
after  puberty,  if  at  all.  Homozygosity  or  compound
heterozygosity  for  MRFP  mutations  does  seem  to  be
associated  with  considerable  reduction  of  axial  length,  as
proposed by others [4,12].
There was considerable phenotypic variability within and
between the families. For example, optic nerve head drusen
were present in one out of four families. The most striking
discordance was found between the two affected sisters in
family 2. One of the sisters (III-3) developed multiple elevated
serous retinal detachments, which had been operated upon
multiple times, albeit without improvement of visual acuity.
She complained of night blindness from 18 years of age, had
poor  visual  acuity,  and  had  a  decreased  pattern  ERG.
Figure 3. Electroretinograms of the patients affected with membrane-type frizzled-related protein, and related oculopathy. Electroretinograms
(ERGs) and pattern ERGs of subject III-1 of family 4 (A), II-1 of family 1 (B), and III-3 of family 2 (C) show severely decreased rod
photoreceptor function and moderately affected cone photoreceptor function. There is a moderate decrease in macular function, as shown by
the pattern ERGs. Though similar ERG findings are seen in individual III-2 of family 2 (D), the pattern ERG is relatively well preserved,
compared to normal case (E).
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545However, her older sister (III-2), who had no serous retinal
detachment, had an unaffected pattern ERG, and had retained
good central vision and visual fields. She did not yet have any
night blindness. The serous detachments could have been due
to a nanophthalmos component of the phenotype. Although
we did not have data on the scleral thickness of the affected
subject, ultrasound examination of subject II-1 of family 1
showed the sclera to be of normal thickness.
The fundus examination of most of the affected subjects
showed  remarkable  similarity  in  the  preservation  of  the
posterior  pole  reflex,  which  corresponded  to  an  ellipsoid
preserved region of autofluorescence (Figure 1 and Figure 2).
Though  not  discussed  in  previous  reports,  the  fundus
photographs of patients from two different groups have a
shown similar pattern of preserved posterior pole reflex [1,
2]. There are no previous data on autofluorescence on affected
subjects with MFRP oculopathy.
Only half of the patients showed the presence of foveal
cysts upon clinical examination or OCT (Figure 2). The OCT
data did not conclusively determine or discount foveal schisis.
This is different from the data published by other groups, in
which foveal schisis was the norm [1-3].
Electrophysiologically,  all  the  ERGs  in  our  patients
showed a rod-cone pattern of dysfunction, with severe rod
system  involvement.  Although  this  is  different  from  the
families described by Sundin et al. [4], whose affected patients
had no retinal degeneration, similar findings have previously
been described [1-3]. In our cases, the scotopic bright flash
Figure  4.  Pedigrees  and  electro-
pherograms of families 1–4. The dark
symbols  in  the  pedigrees  represent
affected  individuals.  The  electro-
pherograms  show  bi-directional
sequencing  of  the  homozygous  c.
1143_1144 insC mutation in family 1
(A),  compound  heterozygous  c.201
G>A and c. 491_492 insT mutations in
family 2 (B), homozygous c.492 delC
mutation  in  family  3  (C),  and
heterozygous  c.1622_1625  delTCTG
mutation  in  family  4  (D).  The
heterozygous  c.492  delC  mutation  in
family 4 is not shown.
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546ERG a- and b-waves were subnormal. They resembled the
delayed cone component of the red flash ERG. This was in
keeping with a dark-adapted cone system origin, exposed in
the presence of severe rod photoreceptor dysfunction. Pattern
ERGs have not been described previously for this condition,
and  ours  were  consistent  with  either  relative  or  complete
sparing of central macular function. Our ERG findings were
not pathognomonic for MFRP mutation, but were consistent
across the individuals tested, and may help identify other
candidates  for  MFRP  screening.  The  ERG  phenotype  is
similar  to  that  observed  in  rd6  mice,  allowing  for  the
differences in retinal structure between man and mouse. It
may be at least partially explained by impaired retinal pigment
epithelium  phagocytosis,  and  by  faulty  development  of
photoreceptor outer segments [13].
Similar to the mutations identified in our families, all but
one  of  the  previously  described  mutations  were  either
frameshift or nonsense [1-4]. The only missense change found
was p.I182P in exon 5 in one family [4]. All but one of the
mutations reported in this series would be expected to cause
nonsense-mediated decay [14], because they would lead to a
premature truncation codon before the 5′-most splice site of
the gene. However, since the mRNA is dicistronic, containing
the  exons  of  the  gene  C1QTNF5  [7],  nonsense-mediated
decay  would  abrogate  expression  of  both  genes.
Immunohistochemistry in the mouse model has shown that in-
frame  deletion  of  Mfrp  failed  to  produce  a  mutant  Mfrp
protein, although the expression of C1qtnf5 was unaffected
[13]. One parsimonious explanation for the effect of these
mutations is that the mutant allele is translated, but the protein
is degraded post-translationally, leading to a null phenotype.
TABLE 3. MUTATIONS FOUND IN FAMILIES 1–4.
Family Mutations Protein Reference
1 c.1143_1144 insC (homo) p.His384Pro fs8X [4]
2 c.201G>A (het) and c.491_492 insT (het) p.Trp67X and p.Asn167Gln fs34X Novel
3 c.492 delC (homo) p.Asn167Thr fs25X [4]
4 c.492 delC (het) and c.1622_1625 delTCTG (het) p.Asn167Thr fs25X and p.Val541Ala fs188X [4] and Novel
The compound heterozygous mutations found in family 2 and one of the compound heterozygous mutations in family 4 are novel.
Figure 5. Structure of membrane-type frizzled-related protein with position of mutations. The upper panel represents the genomic structure
of the dicistronic MFRP-C1QTNF5 with the exons demonstrated as filled boxes and the intervening introns as a line. The small arrows show
the positions of the centromere (11qcen) and the terminal end (11qter) of the large arm of Chromosome 11. In the middle panel, the membrane-
type frizzled-related protein (MFRP) coding region is shown with the untranslated regions colored gray, with ATG representing the start codon
and with the exons numbered from 5′ end to 3′ end. The positions of all the published mutations are shown; the novel mutations are in bold.
The bottom panel shows the coding region and the only published mutation of C1QTNF5 in a similar fashion. All the exons are drawn to
scale.
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547An  alternative  is  that  the  phenotype  is  the  result  of  non-
expression of both MFRP and C1QTNF5, although we feel
that  this  is  unlikely,  given  the  absence  of  any  signs  that
resemble  the  ocular  disorder,  late-onset  retinal  dystrophy,
caused by mutation of C1QTNF5. The p.Val541Ala fs188X
mutation is an exception and would be expected to cause an
elongation of the protein with a new C-terminus. There was
no evidence of association between the type of mutation and
the severity of the phenotype. The three novel mutations that
we  report  in  this  paper  are  either  nonsense  mutations
(p.Trp67X)  or  frameshifts  (p.Asn167Gln  fs34X  and
p.Val541Ala fs188X). Because of the profound effect that
these have in the protein, we have not screened a control panel
for these specific variants.
To  conclude,  we  have  expanded  and  refined  the
phenotypic  description  of  patients  with  the  rod-cone
dystrophy associated with mutations in the MFRP gene. The
clinical  and  electrophysiological  features  described  here
should alert us to the possibility of  MFRP mutation as a
potential cause of similar diseases in other patients.
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